[Skip to Navigation]
Sign In
Correction
October 1, 2021

Error in Discussion

JAMA Netw Open. 2021;4(10):e2133270. doi:10.1001/jamanetworkopen.2021.33270

In the Original Investigation titled “Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database,”1 published September 10, 2021, there was an error in the Discussion. The third sentence of the first paragraph should have read, “First, nearly half of patients (47.58%) showed positivity for nonprescribed substances, particularly for marijuana, benzodiazepines, and gabapentin.” This article has been corrected.1

References
1.
Saloner  B, Whitley  P, LaRue  L, Dawson  E, Huskey  A.  Polysubstance use among patients treated with buprenorphine from a national urine drug test database.   JAMA Netw Open. 2021;4(9):e2123019. doi:10.1001/jamanetworkopen.2021.23019Google Scholar
×